[treatment Of Acute Lymphocytic Leukemia And Growth].

dc.creatorMonteiro, I M
dc.creatorBedone, A J
dc.creatorPinto, C L
dc.creatorBrandalise, S R
dc.date
dc.date2015-11-27T12:19:18Z
dc.date2015-11-27T12:19:18Z
dc.date.accessioned2018-03-29T00:52:55Z
dc.date.available2018-03-29T00:52:55Z
dc.identifierRevista Da Associação Médica Brasileira (1992). v. 44, n. 2, p. 77-80
dc.identifier0104-4230
dc.identifier
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/9699322
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/194214
dc.identifier9699322
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1294447
dc.descriptionThe treatment of the acute lymphocytic leukaemia can determine impaired growth. All the patients had length measurements at the time of the beginning of the treatment and, at least, one year after the end of it. There was impaired growth after the treatment according to the dose regimens (18 or 24 Grays). No relation was observed related to the age at the diagnosis.
dc.description44
dc.description77-80
dc.languagepor
dc.relationRevista Da Associação Médica Brasileira (1992)
dc.relationRev Assoc Med Bras
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAge Factors
dc.subjectBody Height
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectCranial Irradiation
dc.subjectFemale
dc.subjectGrowth
dc.subjectHumans
dc.subjectInfant
dc.subjectPrecursor Cell Lymphoblastic Leukemia-lymphoma
dc.subjectRetrospective Studies
dc.title[treatment Of Acute Lymphocytic Leukemia And Growth].
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución